{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T15:24:43Z","timestamp":1759073083329,"version":"3.41.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1038\/aps.2015.57","type":"journal-article","created":{"date-parts":[[2015,8,4]],"date-time":"2015-08-04T10:22:06Z","timestamp":1438683726000},"page":"949-956","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Involvement of adrenoceptors, dopamine receptors and AMPA receptors in antidepressant-like action of 7-O-ethylfangchinoline in mice"],"prefix":"10.1038","volume":"36","author":[{"given":"Zhao-fu","family":"Sheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang-yu","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Su-ying","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue-qiong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng-jie","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan-li","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya-ping","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-zhi","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-ge","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-he","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,8,3]]},"reference":[{"key":"BFaps201557_CR1","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nrn2649","volume":"10","author":"A Feder","year":"2009","unstructured":"Feder A, Nestler EJ, Charney DS . Psychobiology and molecular genetics of resilience. Nat Rev Neurosci 2009; 10: 446\u201357.","journal-title":"Nat Rev Neurosci"},{"key":"BFaps201557_CR2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0896-6273(02)00653-0","volume":"34","author":"EJ Nestler","year":"2002","unstructured":"Nestler EJ, Barrot M, DiLeone RJ, Eisch AJ, Gold SJ, Monteggia LM . Neurobiology of depression. Neuron 2002; 34: 13\u201325.","journal-title":"Neuron"},{"key":"BFaps201557_CR3","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1016\/j.pnpbp.2005.03.017","volume":"29","author":"M P\u00e1ez-Pereda","year":"2005","unstructured":"P\u00e1ez-Pereda M . New drug targets in the signaling pathways activated by antidepressants. Prog Neuropsychopharmacol Biol Psychiatry 2005; 29: 1010\u20136.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"BFaps201557_CR4","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1017\/S1461145712001496","volume":"17","author":"MJ Millan","year":"2013","unstructured":"Millan MJ . On 'polypharmacy' and multi-target agents, complementary strategies for improving the treatment of depression: a comparative appraisal. Int J Neuropsychopharmacol 2013; 17: 1009\u201337.","journal-title":"Int J Neuropsychopharmacol"},{"key":"BFaps201557_CR5","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.ejphar.2014.07.046","volume":"753","author":"OF O'Leary","year":"2015","unstructured":"O'Leary OF, Dinan TG, Cryan JF . Faster, better, stronger: towards new antidepressant therapeutic strategies. Eur J Pharmacol 2015; 753: 32\u201350.","journal-title":"Eur J Pharmacol"},{"key":"BFaps201557_CR6","doi-asserted-by":"publisher","first-page":"S703","DOI":"10.1016\/j.euroneuro.2011.07.004","volume":"21 Suppl 4","author":"K Demyttenaere","year":"2011","unstructured":"Demyttenaere K . Agomelatine: a narrative review. Eur Neuropsychopharmacol 2011; 21 Suppl 4: S703\u20139.","journal-title":"Eur Neuropsychopharmacol"},{"key":"BFaps201557_CR7","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1021\/np50124a001","volume":"58","author":"P Protais","year":"1995","unstructured":"Protais P, Arbaoui J, Bakkali EH, Bermejo A, Cortes D . Effects of various isoquinoline alkaloids on in vitro3H-dopamine uptake by rat striatal synaptosomes. J Nat Prod 1995; 58: 1475\u201384.","journal-title":"J Nat Prod"},{"key":"BFaps201557_CR8","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.jep.2014.06.054","volume":"155","author":"DK Semwal","year":"2014","unstructured":"Semwal DK, Semwal RB, Vermaak I, Viljoen A . From arrow poison to herbal medicine \u2014 the ethnobotanical, phytochemical and pharmacological significance of Cissampelos (Menispermaceae). J Ethnopharmacol 2014; 155: 1011\u201328.","journal-title":"J Ethnopharmacol"},{"key":"BFaps201557_CR9","first-page":"327","volume":"229","author":"RD Porsolt","year":"1977","unstructured":"Porsolt RD, Bertin A, Jalfre M . Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 1977; 229: 327\u201336.","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"BFaps201557_CR10","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.neuropharm.2009.04.008","volume":"57","author":"BB Gundersen","year":"2009","unstructured":"Gundersen BB, Blendy JA . Effects of the histone deacetylase inhibitor sodium butyrate in models of depression and anxiety. Neuropharmacology 2009; 57: 67\u201374.","journal-title":"Neuropharmacology"},{"key":"BFaps201557_CR11","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/BF00428203","volume":"85","author":"L Steru","year":"1985","unstructured":"Steru L, Chermat R, Thierry B, Simon P . The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology (Berl) 1985; 85: 367\u201370.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFaps201557_CR12","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.pbb.2010.09.011","volume":"97","author":"Q Zhang","year":"2011","unstructured":"Zhang Q, Yu YP, Ye YL, Zhang JT, Zhang WP, Wei EQ . Spatiotemporal properties of locomotor activity after administration of central nervous stimulants and sedatives in mice. Pharmacol Biochem Behav 2011; 97: 577\u201385.","journal-title":"Pharmacol Biochem Behav"},{"key":"BFaps201557_CR13","doi-asserted-by":"publisher","first-page":"9442","DOI":"10.1038\/srep09442","volume":"5","author":"ZJ Wang","year":"2015","unstructured":"Wang ZJ, Zhang XQ, Cui XY, Cui SY, Yu B, Sheng ZF, et al. Glucocorticoid receptors in the locus coeruleus mediate sleep disorders caused by repeated corticosterone treatment. Sci Rep 2015; 5: 9442.","journal-title":"Sci Rep"},{"key":"BFaps201557_CR14","first-page":"Unit 8.10A","volume":"Chapter 8","author":"V Castagn\u00e9","year":"2011","unstructured":"Castagn\u00e9 V, Moser P, Roux S, Porsolt RD . Rodent models of depression: forced swim and tail suspension behavioral despair tests in rats and mice. Curr Protoc Neurosci 2011; Chapter 8: Unit 8.10A.","journal-title":"Curr Protoc Neurosci"},{"key":"BFaps201557_CR15","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/0149-7634(94)00050-B","volume":"19","author":"F Borsini","year":"1995","unstructured":"Borsini F . Role of the serotonergic system in the forced swimming test. Neurosci Biobehav Rev 1995; 19: 377\u201395.","journal-title":"Neurosci Biobehav Rev"},{"key":"BFaps201557_CR16","first-page":"24","volume":"27","author":"Y Chen","year":"2011","unstructured":"Chen Y, Chen M, Sun C, Li D . Study on acute toxicity of tetrandrine in male SD rats by intragastric administration. J Pract Med 2011; 27: 24\u20135. Chinese.","journal-title":"J Pract Med"},{"key":"BFaps201557_CR17","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.pnpbp.2003.11.018","volume":"28","author":"AS Elhwuegi","year":"2004","unstructured":"Elhwuegi AS . Central monoamines and their role in major depression. Prog Neuropsychopharmacol Biol Psychiatry 2004; 28: 435\u201351.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"BFaps201557_CR18","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.ejphar.2004.07.038","volume":"500","author":"MJ Millan","year":"2004","unstructured":"Millan MJ . The role of monoamines in the actions of established and \u201cnovel\u201d antidepressant agents: a critical review. Eur J Pharmacol 2004; 500: 371\u201384.","journal-title":"Eur J Pharmacol"},{"key":"BFaps201557_CR19","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/S0924-977X(02)00057-3","volume":"12","author":"N Brunello","year":"2002","unstructured":"Brunello N, Mendlewicz J, Kasper S, Leonard B, Montgomery S, Nelson J, et al. The role of noradrenaline and selective noradrenaline reuptake inhibition in depression. Eur Neuropsychopharmacol 2002; 12: 461\u201375.","journal-title":"Eur Neuropsychopharmacol"},{"key":"BFaps201557_CR20","first-page":"S39","volume":"11 Suppl 4","author":"BE Leonard","year":"1997","unstructured":"Leonard BE . The role of noradrenaline in depression: a review. J Psychopharmacol 1997; 11 Suppl 4: S39\u201347.","journal-title":"J Psychopharmacol"},{"key":"BFaps201557_CR21","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1097\/00004850-200307000-00001","volume":"18","author":"N Brunello","year":"2003","unstructured":"Brunello N, Blier P, Judd LL, Mendlewicz J, Nelson CJ, Souery D, et al. Noradrenaline in mood and anxiety disorders: basic and clinical studies. Int Clin Psychopharmacol 2003; 18: 191\u2013202.","journal-title":"Int Clin Psychopharmacol"},{"key":"BFaps201557_CR22","first-page":"3","volume":"67 Suppl 6","author":"DJ Nutt","year":"2006","unstructured":"Nutt DJ . The role of dopamine and norepinephrine in depression and antidepressant treatment. J Clin Psychiatry 2006; 67 Suppl 6: 3\u20138.","journal-title":"J Clin Psychiatry"},{"key":"BFaps201557_CR23","first-page":"285","volume":"38","author":"W Danysz","year":"1986","unstructured":"Danysz W, Kostowski W, Kozak W, Hauptmann M . On the role of noradrenergic neurotransmission in the action of desipramine and amitriptyline in animal models of depression. Pol J Pharmacol Pharm 1986; 38: 285\u201398.","journal-title":"Pol J Pharmacol Pharm"},{"key":"BFaps201557_CR24","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ejphar.2007.03.003","volume":"565","author":"MP Kaster","year":"2007","unstructured":"Kaster MP, Raupp I, Binfar\u00e9 RW, Andreatini R, Rodrigues ALS . Antidepressant-like effect of lamotrigine in the mouse forced swimming test: evidence for the involvement of the noradrenergic system. Eur J Pharmacol 2007; 565: 119\u201324.","journal-title":"Eur J Pharmacol"},{"key":"BFaps201557_CR25","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.neulet.2003.09.033","volume":"353","author":"EA Stone","year":"2003","unstructured":"Stone EA, Lin Y, Quartermain D . Immobility from administration of the alpha1-adrenergic antagonist, terazosin, in the IVth ventricle in rats. Neurosci Lett 2003; 353: 231\u20133.","journal-title":"Neurosci Lett"},{"key":"BFaps201557_CR26","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1046\/j.1460-9568.2003.02510.x","volume":"17","author":"G Flugge","year":"2003","unstructured":"Flugge G, van Kampen M, Meyer H, Fuchs E . Alpha2A and alpha2C-adrenoceptor regulation in the brain: alpha2A changes persist after chronic stress. Eur J Neurosci 2003; 17: 917\u201328.","journal-title":"Eur J Neurosci"},{"key":"BFaps201557_CR27","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/(SICI)1098-2396(200002)35:2<79::AID-SYN1>3.0.CO;2-X","volume":"35","author":"MJ Millan","year":"2000","unstructured":"Millan MJ, Newman-Tancredi A, Audinot V, Cussac D, Lejeune F, Nicolas JP, et al. Agonist and antagonist actions of yohimbine as compared to fluparoxan at alpha(2)-adrenergic receptors (AR)s, serotonin (5-HT)(1A), 5-HT(1B), 5-HT(1D) and dopamine D(2) and D(3) receptors. Significance for the modulation of frontocortical monoaminergic transmission and depressive states. Synapse 2000; 35: 79\u201395.","journal-title":"Synapse"},{"key":"BFaps201557_CR28","first-page":"143","volume":"35","author":"MR Goldberg","year":"1983","unstructured":"Goldberg MR, Robertson D . Yohimbine: a pharmacological probe for study of the alpha2-adrenoceptor. Pharmacol Rev 1983; 35: 143\u201380.","journal-title":"Pharmacol Rev"},{"key":"BFaps201557_CR29","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0022-3565(25)22769-0","volume":"271","author":"JM O'Donnell","year":"1994","unstructured":"O'Donnell JM, Frith S, Wilkins J . Involvement of beta-1 and beta-2 adrenergic receptors in the antidepressant-like effects of centrally administered isoproterenol. J Pharmacol Exp Ther 1994; 271: 246\u201354.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFaps201557_CR30","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1111\/j.1472-8206.2004.00287.x","volume":"18","author":"E Dailly","year":"2004","unstructured":"Dailly E, Chenu F, Renard CE, Bourin M . Dopamine, depression and antidepressants. Fundam Clin Pharmacol 2004; 18: 601\u20137.","journal-title":"Fundam Clin Pharmacol"},{"key":"BFaps201557_CR31","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1001\/archpsyc.64.3.327","volume":"64","author":"BW Dunlop","year":"2007","unstructured":"Dunlop BW, Nemeroff CB . The role of dopamine in the pathophysiology of depression. Arch Gen Psychiatry 2007; 64: 327\u201337.","journal-title":"Arch Gen Psychiatry"},{"key":"BFaps201557_CR32","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.pnpbp.2013.12.011","volume":"50","author":"N Takamura","year":"2014","unstructured":"Takamura N, Nakagawa S, Masuda T, Boku S, Kato A, Song N, et al. The effect of dopamine on adult hippocampal neurogenesis. Prog Neuropsychopharmacol Biol Psychiatry 2014; 50: 116\u201324.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"BFaps201557_CR33","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/S0014-2999(00)00566-5","volume":"405","author":"PS D'Aquila","year":"2000","unstructured":"D'Aquila PS, Collu M, Gessa GL, Serra G . The role of dopamine in the mechanism of action of antidepressant drugs. Eur J Pharmacol 2000; 405: 365\u201373.","journal-title":"Eur J Pharmacol"},{"key":"BFaps201557_CR34","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1097\/00002826-200309000-00005","volume":"26","author":"H Takahashi","year":"2003","unstructured":"Takahashi H, Yoshida K, Higuchi H, Shimizu T, Inoue T, Koyama T . Addition of a dopamine agonist, cabergoline, to a serotonin-noradrenalin reuptake inhibitor, milnacipran as a therapeutic option in the treatment of refractory depression: two case reports. Clin Neuropharmacol 2003; 26: 230\u20132.","journal-title":"Clin Neuropharmacol"},{"key":"BFaps201557_CR35","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.bbr.2014.11.016","volume":"279","author":"Y Li","year":"2015","unstructured":"Li Y, Zhu ZR, Ou BC, Wang YQ, Tan ZB, Deng CM, et al. Dopamine D2\/D3 but not dopamine D1 receptors are involved in the rapid antidepressant-like effects of ketamine in the forced swim test. Behav Brain Res 2015; 279: 100\u20135.","journal-title":"Behav Brain Res"},{"key":"BFaps201557_CR36","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/cns.12103","volume":"19","author":"G Salvadore","year":"2013","unstructured":"Salvadore G, Singh JB . Ketamine as a fast acting antidepressant: current knowledge and open questions. CNS Neurosci Ther 2013; 19: 428\u201336.","journal-title":"CNS Neurosci Ther"},{"key":"BFaps201557_CR37","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","volume":"63","author":"CA Zarate","year":"2006","unstructured":"Zarate CA Jr, Singh JB, Carlson PJ, Brutsche NE, Ameli R, Luckenbaugh DA, et al. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry 2006; 63: 856\u201364.","journal-title":"Arch Gen Psychiatry"},{"key":"BFaps201557_CR38","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.pharmthera.2009.02.010","volume":"123","author":"R Machado-Vieira","year":"2009","unstructured":"Machado-Vieira R, Salvadore G, DiazGranados N, Zarate CA . Ketamine and the next generation of antidepressants with a rapid onset of action. Pharmacol Ther 2009; 123: 143\u201350.","journal-title":"Pharmacol Ther"},{"key":"BFaps201557_CR39","first-page":"1101","volume":"9","author":"KA Lapidus","year":"2013","unstructured":"Lapidus KA, Soleimani L, Murrough JW . Novel glutamatergic drugs for the treatment of mood disorders. Neuropsychiatr Dis Treat 2013; 9: 1101\u201312.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"BFaps201557_CR40","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1016\/j.bcp.2005.12.022","volume":"71","author":"A Alt","year":"2006","unstructured":"Alt A, Nisenbaum ES, Bleakman D, Witkin JM . A role for AMPA receptors in mood disorders. Biochem Pharmacol 2006; 71: 1273\u201388.","journal-title":"Biochem Pharmacol"},{"key":"BFaps201557_CR41","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1177\/0269881112458728","volume":"26","author":"KR Nations","year":"2012","unstructured":"Nations KR, Dogterom P, Bursi R, Schipper J, Greenwald S, Zraket D, et al. Examination of Org 26576, an AMPA receptor positive allosteric modulator, in patients diagnosed with major depressive disorder: an exploratory, randomized, double-blind, placebo-controlled trial. J Psychopharmacol 2012; 26: 1525\u201339.","journal-title":"J Psychopharmacol"},{"key":"BFaps201557_CR42","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.bbr.2011.05.035","volume":"224","author":"H Koike","year":"2011","unstructured":"Koike H, Iijima M, Chaki S . Involvement of AMPA receptor in both the rapid and sustained antidepressant-like effects of ketamine in animal models of depression. Behav Brain Res 2011; 224: 107\u201311.","journal-title":"Behav Brain Res"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/aps201557.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/aps201557","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/aps201557.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T21:35:49Z","timestamp":1748554549000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/aps201557"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":42,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["BFaps201557"],"URL":"https:\/\/doi.org\/10.1038\/aps.2015.57","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"type":"print","value":"1671-4083"},{"type":"electronic","value":"1745-7254"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"27 March 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}